CAMH is pleased to announce that following an international search, Dr. Aristotle Voineskos has been appointed Vice President Research. He will start in this role on January 1, 2021.
Dr. Voineskos has an outstanding track-record as a clinician, a scientist, and a leader, driving change to improve care for people with mental illness. He takes on this role at a pivotal time for CAMH and the mental health movement. Research is central to the CAMH mission and its importance is reflected in all three directions of our new strategic plan, One CAMH. At this important juncture, he will build on research success of the past decade, and work to accelerate the discovery and innovation that will create hope for the people we serve.
Dr. Voineskos has held a number of administrative positions and appointments at CAMH, including Chief of the Schizophrenia Division and Director of the Slaight Centre. He is a Professor in the Department of Psychiatry at the University of Toronto, holds a Canada Research Chair, and serves on the Scientific Council of the Brain and Behavior Research Foundation (BBRF). In addition, he has led large-scale initiatives across disciplines funded by the Canadian Institutes of Health Research, National Institute of Mental Health in the U.S., and philanthropic agencies. His scientific impact ranges from brain mapping in mental illness to scaling system-level initiatives in mental health care. He is a dedicated teacher and mentor, supporting numerous students and postgraduate fellows as they launch their own careers.
“I am excited to take on the VP Research role at this critical time. CAMH’s research enterprise continues to grow. We have an impressive array of strengths across the board from molecular neuroscience, to brain imaging, clinical trials, health services and policy. Our future is in team-based science, integration across disciplines, and bringing our discoveries to our patients. Research discovery can defeat prejudice and discrimination. We have a unique opportunity to build a future filled with hope for those suffering from mental illness”, said Dr. Voineskos.
Dr. Voineskos will formally begin his role on January 1, 2021.
CAMH is Canada’s largest mental health teaching hospital and one of the world’s leading research centres in the field. CAMH is fully affiliated with the University of Toronto and is a Pan American Health Organization/World Health Organization Collaborating Centre.
CAMH advocates for equitable mental health resources and supports in Canada’s publicly-funded health care system. CAMH deploys new treatments and implements new models of care and support. CAMH builds new spaces to support recovery and community reintegration. As the population ages and diversifies, and new technologies revolutionize day to day lives, this changing landscape compels CAMH to reconsider the meaning of health. CAMH”s mission is that mental health is health animates its mission: integrated care, answering the most difficult questions about mental illness and removing barriers to belonging.